Fyarro
Fyarro entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.
Timeline
Thu, 06 Aug 2026 20:11:01 GMTWhitehawk Therapeutics 2Q 2026: Revenue $0 Net loss $16.64M, EPS $(0.20) — 10-Q Summary - TradingView
Thu, 06 Aug 2026 20:05:47 GMTWHWK: Net loss of $38.8M in H1 2026; $190M cash; advancing ADC pipeline after FYARRO divestiture - TradingView
Related explainers
Connected entities
FAQ
What does this page track?
Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Fyarro.
Why might this page be noindex?
Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.
Where should readers verify facts?
Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.
Source diversity
1 distinct publisher/source names are currently connected to this entity page.